FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer
Links shared publicly online about this topic.
- 382total visits
FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer
View full resource at onclive.com
Tags: Cancer, Thyroid Cancer, Medullary Thyroid Cancer, FDA
Most Recently Shared on April 7, 2011 at 9:48 pm By:
FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer http://goo.gl/MtWfZ
Symposier - Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance
symposier.com — “Uploaded and shared in Youtube by: mdandersonorg — In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert Gagel who with his team helped to bring about the FDA's approval of vandetanib talks about the drug, the research and it's benefit to medullary thyroid cancer patients.” View full resource at symposier.com
Most Recently Shared on May 25, 2011 at 3:25 pm By:
Symposier Endocrino Health Site
Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance. http://bit.ly/mbMIhJ
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer
drugs.com — “Vandetanib is used to treat advanced medullary thyroid cancer. Includes vandetanib side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 11, 2011 at 12:50 am By:
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer - http://bit.ly/hiHKy2
FDA Approves Orphan Drug Vandetanib For Advanced Medullary Thyroid Cancer
medicalnewstoday.com — “AstraZeneca (NYSE: AZN) has announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by s” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2011 at 9:05 am By:
NatureRevEndocrinol Endocrinology and Medical Journal
RT @mnt_endocrine: FDA Approves Orphan Drug Vandetanib For Advanced Medullary Thyroid Cancer http://mnt.to/3Tpj #endocrinology
FDA Approves Vandetanib For Medullary Thyroid Cancer
medicalnewstoday.com — “Vandetanib has been approved by the FDA (Food and Drug Administration) for the treatment of late-stage medullary thyroid cancer in adults who cannot have surgery, and whose disease is progressing” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2011 at 12:36 am By:
Ear, Nose, and Throat OW Health
FDA Approves Vandetanib For Medullary Thyroid Cancer: Vandetanib has been approved by the FDA (Food and Drug Adm... http://bit.ly/dQWJOu
FDA Okays First Treatment for Rare Thyroid Cancer - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at qualitypointtech.net
Most Recently Shared on April 7, 2011 at 9:00 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer: WASHINGTON (MedPage Today) -- The FDA has approved vandetanib f... http://bit.ly/ftqNvm
Medical News: FDA Okays First Treatment for Rare Thyroid Cancer - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2011 at 8:44 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer http://bit.ly/hpX6ZE
Medical News: FDA Okays First Treatment for Rare Thyroid Cancer - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2011 at 8:39 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer: WASHINGTON (MedPage Today) -- The FDA has… http://goo.gl/fb/3BaXg
FDA Approves Vandetanib For Medullary Thyroid Cancer
medicalnewstoday.com — “Vandetanib has been approved by the FDA (Food and Drug Administration) for the treatment of late-stage medullary thyroid cancer in adults who cannot have surgery, and whose disease is progressing” View full resource at medicalnewstoday.com
Most Recently Shared on April 7, 2011 at 6:05 pm By:
MNT Drug Approvals Health News
FDA Approves Vandetanib For Medullary Thyroid Cancer http://mnt.to/3TmV #regulatory
Vandetanib Approved for Metastatic Medullary Thyroid Cancer - MPR
empr.com — “The FDA has approved the orphan drug vandetanib (AstraZeneca), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on April 7, 2011 at 2:19 pm By:
MPR News: Vandetanib Approved for Metastatic Medullary Thyroid Cancer: The FDA has approved the orphan drug vand... http://bit.ly/eF20pY
Vandetanib Approved for Metastatic Medullary Thyroid Cancer - ONA
oncologynurseadvisor.com — “The FDA has approved the orphan drug vandetanib (AstraZeneca), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 7, 2011 at 2:14 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Vandetanib Approved for Metastatic Medullary Thyroid Cancer http://goo.gl/fb/MUbjb
FDA Approves AstraZeneca's Thyroid Cancer Drug - FoxNews.com
foxnews.com — “The U.S. health regulator on Wednesday approved AstraZeneca Plc's medullary thyroid cancer drug, vandetanib, the first treatment to be approved for the rare form of cancer” View full resource at foxnews.com
Most Recently Shared on April 7, 2011 at 1:58 pm By:
Health,Fitness,Diet Health Business
FDA Approves AstraZeneca's Thyroid Cancer Drug http://bit.ly/ijYf3Y
FDA Approves New Treatment For Rare Form Of Thyroid Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease th” View full resource at medicalnewstoday.com
Most Recently Shared on April 7, 2011 at 12:42 pm By:
Endocrinology Wisdom OW Health
FDA Approves New Treatment For Rare Form Of Thyroid Cancer: The U.S. Food and Drug Administration today approved... http://bit.ly/hNAXWm
AstraZeneca's vandetanib receives FDA orphan drug designation in medullary thyroid cancer
news-medical.net — “AstraZeneca today announced that the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.” View full resource at news-medical.net
Most Recently Shared on April 7, 2011 at 10:19 am By:
News-Medical.Net Oncology and Health News
Oncology News: AstraZeneca's vandetanib receives FDA orphan drug designation in medullary thyroid cancer: AstraZ... http://bit.ly/dNfKm5
Thyroid cancer drug: FDA approves first drug for form of thyroid cancer - Health Key
healthkey.com — “Federal regulators Wednesday approved the first drug treatment for metastatic medullary thyroid cancer, a rare form of late-stage thyroid cancer. The drug, vandetanib, helped stall the disease's progression for an average of six months, the Food and Drug Administration says.” View full resource at healthkey.com
Most Recently Shared on April 7, 2011 at 8:15 am By:
Hisham Rana, MD Doctor and Physician
News: U.S. #FDA approves first drug for form of thyroid #cancer http://bit.ly/eajHbI - Vandetanib. #health #pharma
Advertisement
